Radiology CME

Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 0.75 CME
National Jewish Health
Examining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care
Gary Cunningham
20 November, 2018
Credits: 0.50 CME
Penn State College of Medicine
Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy
Kristin Highland, MD, MSCR
3 August, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment
Lisa Lancaster, MD
31 July, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Achieving Early and Accurate Diagnosis of Interstitial Lung Disease
Jonathan G. Goldin, MD, PhD / David J. Lederer, MD, MS
11 June, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
Riccardo Lencioni, MD, FSIR, EBIR
2 May, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
Anas Younes, MD
4 April, 2018
Credits: 1.50 CME / CE / CPE
Medical Learning Institute, Inc.
Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes
Ezra Cohen, MD, FRCPC, FASCO
27 March, 2018
Credits: 1.00 CME / CE
Medical Learning Institute, Inc.
Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
Ghassan Abou-Alfa, MD, MBA
26 March, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
Ghassan Abou-Alfa, MD, MBA
8 March, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Naiyer Rizvi, MD
2 March, 2018